Myeloma

Defining the Biologic and Therapeutic Significance of the Novel Long Noncoding RNA MYND in Multiple Myeloma

The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member

banner-list-news.jpg

Targeting splicing factor mutant myelodysplastic syndromes through GSK-3

Anti-Sox2 immunotherapy to prevent multiple myeloma relapse

Dissecting the biology and exploiting the dependency of myeloma cells on P300/CBP

Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma

LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling

scotus-4-7_dam_file_138751.png

Identification and Molecular Analysis of Pre-Myelofibrotic Stem Cells

Targeting the MMP-13/PD-1H signaling axis for multiple myeloma bone disease and immunosuppression

Myeloma

Defining the Biologic and Therapeutic Significance of the Novel Long Noncoding RNA MYND in Multiple Myeloma

Investigating the Role of ASXL1 Mutations in CALR-mutated Myeloproliferative Neoplasms

The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member

Targeting splicing factor mutant myelodysplastic syndromes through GSK-3

Anti-Sox2 immunotherapy to prevent multiple myeloma relapse

Dissecting the biology and exploiting the dependency of myeloma cells on P300/CBP

Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma

LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling

Identification and Molecular Analysis of Pre-Myelofibrotic Stem Cells

Targeting the MMP-13/PD-1H signaling axis for multiple myeloma bone disease and immunosuppression

Myeloma